Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 76

1.

Novel adjuvant boosts HIV and influenza vaccines in mice.

Patel J.

Expert Rev Vaccines. 2012 Oct;11(10):1167. No abstract available.

PMID:
23320260
2.

Novel adjuvants and delivery systems for HIV vaccines.

O'Hagan DT, Lavelle E.

AIDS. 2002;16 Suppl 4:S115-24. Review. No abstract available.

PMID:
12699008
3.

[Chitosan as an adjuvant for parenteral inactivated influenza vaccines].

Gendon IuZ, Markushin SG, Krivtsov GG, Akopova II.

Vopr Virusol. 2008 Sep-Oct;53(5):14-9. Russian.

PMID:
19069787
4.

Chitosan as an adjuvant for parenterally administered inactivated influenza vaccines.

Ghendon Y, Markushin S, Krivtsov G, Akopova I.

Arch Virol. 2008;153(5):831-7. doi: 10.1007/s00705-008-0047-4. Epub 2008 Feb 23.

PMID:
18297235
5.

[Influenza vaccines adjuvants--contemporary state].

Vasil'ev IuM.

Zh Mikrobiol Epidemiol Immunobiol. 2010 Jan-Feb;(1):100-10. Review. Russian.

PMID:
20218354
6.

Stimulation of protective and cross-protective immunity against influenza B virus after adjuvant mucosal immunization of mice.

Prokesová L, Zanvit P, Havlícková M, Tácner J, Jirkovská M, Petrásková P, Novotná O, Cechová D, Julák J.

Folia Microbiol (Praha). 2009 Nov;54(6):549-52. doi: 10.1007/s12223-009-0080-z. Epub 2010 Feb 7.

PMID:
20140725
7.
8.

The utility of ISCOMATRIX adjuvant for dose reduction of antigen for vaccines requiring antibody responses.

Boyle J, Eastman D, Millar C, Camuglia S, Cox J, Pearse M, Good J, Drane D.

Vaccine. 2007 Mar 30;25(14):2541-4. Epub 2006 Dec 29.

PMID:
17240491
9.
10.

Adjuvants for pandemic influenza vaccines.

Atmar RL, Keitel WA.

Curr Top Microbiol Immunol. 2009;333:323-44. doi: 10.1007/978-3-540-92165-3_16. Review.

PMID:
19768413
11.

[Avian influenza vaccines].

Vasil'ev IuM.

Vopr Virusol. 2008 Nov-Dec;53(6):4-15. Review. Russian.

PMID:
19172900
12.

Microparticles in MF59, a potent adjuvant combination for a recombinant protein vaccine against HIV-1.

O'Hagan DT, Ugozzoli M, Barackman J, Singh M, Kazzaz J, Higgins K, Vancott TC, Ott G.

Vaccine. 2000 Mar 6;18(17):1793-801.

PMID:
10699327
13.

Efficacy, immunogenicity and stability of a novel intranasal nanoemulsion-adjuvanted influenza vaccine in a murine model.

Hamouda T, Chepurnov A, Mank N, Knowlton J, Chepurnova T, Myc A, Sutcliffe J, Baker JR.

Hum Vaccin. 2010 Jul;6(7):585-94.

PMID:
20421727
14.

Oral adjuvant activity for nasal influenza vaccines caused by combination of two trihydroxy fatty acid stereoisomers from the tuber of Pinellia ternata.

Nagai T, Shimizu Y, Shirahata T, Sunazuka T, Kiyohara H, Omura S, Yamada H.

Int Immunopharmacol. 2010 Jun;10(6):655-61. doi: 10.1016/j.intimp.2010.03.004. Epub 2010 Mar 15.

PMID:
20230917
15.

Novel vaccines and adjuvants.

Buonaguro L.

Curr HIV Res. 2010 Jun;8(4):273. No abstract available.

PMID:
20462398
16.

Evaluation of properties of chitosan as an adjuvant for inactivated influenza vaccines administered parenterally.

Ghendon Y, Markushin S, Vasiliev Y, Akopova I, Koptiaeva I, Krivtsov G, Borisova O, Ahmatova N, Kurbatova E, Mazurina S, Gervazieva V.

J Med Virol. 2009 Mar;81(3):494-506. doi: 10.1002/jmv.21415.

PMID:
19152418
17.

Cytokines as adjuvants for improving anti-HIV responses.

Morrow MP, Weiner DB.

AIDS. 2008 Jan 30;22(3):333-8. doi: 10.1097/QAD.0b013e3282f42461. Review. No abstract available.

PMID:
18195559
18.

The Eurocine L3 adjuvants with subunit influenza antigens induce protective immunity in mice after intranasal vaccination.

Petersson P, Hedenskog M, Alves D, Brytting M, Schröder U, Linde A, Lundkvist A.

Vaccine. 2010 Sep 7;28(39):6491-7. doi: 10.1016/j.vaccine.2010.07.001. Epub 2010 Jul 15.

PMID:
20637767
19.

Single dose intranasal immunization with ISCOMATRIX vaccines to elicit antibody-mediated clearance of influenza virus requires delivery to the lower respiratory tract.

Sanders MT, Deliyannis G, Pearse MJ, McNamara MK, Brown LE.

Vaccine. 2009 Apr 21;27(18):2475-82. doi: 10.1016/j.vaccine.2009.02.054. Epub 2009 Feb 24.

PMID:
19368789
20.

[Chitosan as an adjuvant for inactivated vaccines against avian influenza viruses].

Gendon IuZ, Vasil'ev IuM, Markushin SG, Akopova II, Koptiaeva IB, Krivtsov GG.

Zh Mikrobiol Epidemiol Immunobiol. 2009 Mar-Apr;(2):40-7. Russian.

PMID:
19459476
Items per page

Supplemental Content

Write to the Help Desk